$ZWS

Zurn Elkay Water Solutions Corp

0
0
1
$100K
Butler Jacques Donavon
0%
See all $ZWS insider activity →
Med

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

Zurn Elkay director Jacques Butler buys $99,993 in company stock

Zurn Elkay Water Solutions Corp (ZWS) director Jacques Butler bought 2,016 shares at $49.6 each, totaling $99,993. The company reported Q2 2026 earnings of $0.50 per share, beating estimates, with revenue of $491 million. Stifel maintained a Buy rating and $62 price target. ZWS has a market cap of $8.1 billion and a P/E ratio of 30.38.

ZWS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ZWS (Zurn Elkay Water Solutions Corp). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent ZWS coverage spans earnings, financial news and insider activity.

In the last 30 days, ZWS insiders filed 1 SEC Form 4 transaction — 1 purchase ($100K) and no sales. The most active reporter was Butler Jacques Donavon with 1 filing.

What's driving ZWS

AlphAI scores every news story that mentions ZWS with an AI model for sentiment and relevance, and aggregates insider trades from Zurn Elkay Water Solutions Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ZWS

Score
$AAONMed

Q2 Earnings Highlights: A.O. Smith (NYSE:AOS) Vs The Rest Of The HVAC and Water Systems Stocks

AAON (NYSE:AOS) beat analyst estimates and reported fastest revenue growth among HVAC peers, but its stock is down 19.2%. Lennox (NYSE:LII) missed revenue expectations, with stock down 29.4%. Trane Technologies (NYSE:TT) and Zurn Elkay (NYSE:ZWS) both exceeded revenue estimates, but their stocks are down 1.5% and 7.7% respectively. Market focus has shifted from AI to geopolitics and back to fundamentals.

How Stronger EPS And Completed Buybacks At Zurn Elkay Water Solutions (ZWS) Have Changed Its Investment Story

Simply Wall St reports Zurn Elkay Water Solutions (ZWS) posted Q2 2026 sales of $491M and net income of $113.3M, and six-month sales of $924M and net income of $172.2M, both up year over year. The company completed a $760.26M buyback, retiring 24M+ shares. The article cites 2029 forecasts of $2.2B revenue and $361.3M earnings and fair value estimates near $57.07 to $58.10.

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.

$ZWSMedAI 8/10

Zurn Water: Q2 Earnings Snapshot

Zurn Water Solutions (ZWS) reported Q2 profit of $113.3 million, or 67 cents per share. Adjusted earnings were 50 cents per share versus a Zacks/Wall Street estimate of 47 cents. Revenue was $491 million, above the $482.4 million expected by analysts surveyed by Zacks.

$ZWSMedAI 8/10

Zurn Elkay (NYSE:ZWS) Posts Better

Zurn Elkay (NYSE:ZWS) reported Q2 CY2026 results. Revenue rose 10.5% year on year to $491 million and exceeded Wall Street estimates by 1.6%. Non-GAAP profit was $0.50 per share, 5.8% above consensus. The company said it is raising its full-year outlook and repurchased $50 million of shares in the quarter.

Related tickers